Harbor Investment Advisory LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 10.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,635 shares of the medical equipment provider’s stock after purchasing an additional 254 shares during the period. Harbor Investment Advisory LLC’s holdings in Intuitive Surgical were worth $1,375,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in the stock. Mirador Capital Partners LP increased its stake in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the fourth quarter worth about $82,517,000. Exome Asset Management LLC boosted its holdings in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp grew its stake in shares of Intuitive Surgical by 17.4% in the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after buying an additional 1,198 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
ISRG has been the topic of a number of recent analyst reports. Mizuho upped their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Finally, Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $554.17.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $592.64 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68. The stock has a market capitalization of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. The stock has a 50-day simple moving average of $540.66 and a 200-day simple moving average of $499.64.
Insider Buying and Selling
In other Intuitive Surgical news, EVP Robert Desantis sold 1,012 shares of the firm’s stock in a transaction on Friday, October 25th. The stock was sold at an average price of $514.00, for a total value of $520,168.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,830,084. This trade represents a 15.53 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,509 shares of company stock worth $22,602,212 over the last 90 days. 0.80% of the stock is owned by insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Conference Calls and Individual Investors
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Trading Halts Explained
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.